tiprankstipranks
Trending News
More News >
Venus Medtech (Hangzhou), Inc. Class H (HK:2500)
:2500
Hong Kong Market

Venus Medtech (Hangzhou), Inc. Class H (2500) Financial Statements

Compare
0 Followers

Venus Medtech (Hangzhou), Inc. Class H Financial Overview

Venus Medtech (Hangzhou), Inc. Class H's market cap is currently HK$1.16B. The company's EPS TTM is HK$-1.258; its P/E ratio is ―; Venus Medtech (Hangzhou), Inc. Class H is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 470.83M¥ 491.37M¥ 406.46M¥ 415.86M¥ 276.05M
Gross Profit¥ 367.75M¥ 389.20M¥ 314.00M¥ 324.34M¥ 227.28M
Operating Income¥ -346.60M¥ -589.97M¥ -1.09B¥ -621.53M¥ -237.25M
EBITDA¥ -612.96M¥ -547.84M¥ -999.37M¥ -324.03M¥ -152.83M
Net Income¥ -714.31M¥ -703.75M¥ -1.12B¥ -371.39M¥ -182.87M
Balance Sheet
Cash & Short-Term Investments¥ 305.70M¥ 781.64M¥ 1.88B¥ 2.96B¥ 2.75B
Total Assets¥ 3.25B¥ 4.41B¥ 5.28B¥ 5.11B¥ 4.32B
Total Debt¥ 369.09M¥ 826.19M¥ 899.64M¥ 70.78M¥ 32.76M
Net Debt¥ 71.05M¥ 51.79M¥ -979.79M¥ -2.88B¥ -2.68B
Total Liabilities¥ 1.04B¥ 1.49B¥ 1.65B¥ 477.61M¥ 461.19M
Stockholders' Equity¥ 2.21B¥ 2.92B¥ 3.61B¥ 4.55B¥ 3.82B
Cash Flow
Free Cash Flow¥ -17.82M¥ -872.93M¥ -908.23M¥ -602.08M¥ -361.05M
Operating Cash Flow¥ 23.74M¥ -610.02M¥ -729.46M¥ -456.92M¥ -237.00M
Investing Cash Flow¥ -19.90M¥ -346.86M¥ -1.07B¥ -653.04M¥ -297.94M
Financing Cash Flow¥ -487.34M¥ -173.99M¥ 635.14M¥ 1.39B¥ 927.75M
Currency in CNY

Venus Medtech (Hangzhou), Inc. Class H Earnings and Revenue History

Venus Medtech (Hangzhou), Inc. Class H Debt to Assets

Venus Medtech (Hangzhou), Inc. Class H Cash Flow

Venus Medtech (Hangzhou), Inc. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis